As decision on new Alzheimer's drug nears, Biogen aims for redemption
A new therapy for the memory-robbing brain disease, made by Biogen and Eisai, could be approved in early January, despite questions about its safety, potential cost, and availability.
Sunday, January 1, 2023 at 11:14 pm